68Ga-UZBRU-VHH2

DRUG2 trials

Sponsors

Cliniques Universitaires Saint-Luc, UZ Brussel

Conditions

Cardiac sarcoidosisPatients with non-small cell lung cancer

Phase 2

Phase II study to assess in vivo imaging of MMR-expressing macrophages in cardiac sarcoidosis using 68Ga-NOTA-Anti-MMR-VHH2 Positron Emission Tomography (PET).

Not yet recruitingCTIS2024-512473-27-00

Cliniques Universitaires Saint-LucCardiac sarcoidosis

Target: 15Updated: 2024-09-25

A phase II study to evaluate the imaging potential of 68GaNOTA-Anti-MMR VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-small cell lung cancer (NSCLC).

RecruitingCTIS2024-514138-19-00

UZ BrusselPatients with non-small cell lung cancer

Start: 2023-02-15Target: 20Updated: 2025-04-18